SPARC's Innovative Research Drives Impressive 7.86% Stock Market Gain
SPARC, a midcap pharmaceutical company, gained 7.86% in the stock market on November 22, 2024. Despite being rated as 'Strong Sell' by MarketsMojo, the company has outperformed the sector by 6.73%. Its strong performance can be attributed to its focus on research and development, leading to the development of innovative products.
Sun Pharma Advanced Research Company (SPARC) has shown a strong performance in the stock market, gaining 7.86% on November 22, 2024. This midcap pharmaceutical company has been making waves in the industry with its innovative research and development efforts.
According to MarketsMOJO, a leading stock market analysis platform, the stock call for SPARC is currently 'Strong Sell'. However, the company's recent performance has been impressive, outperforming the sector by 6.73% on the same day.
The stock reached an intraday high of Rs 205, showing a significant increase of 7.39%. While the stock's moving averages are higher than the 5-day average, they are lower than the 20-day, 50-day, 100-day, and 200-day averages.
In comparison to the overall market performance, SPARC has outperformed the Sensex by a significant margin. On the same day, the company's 1-day performance was 8.36%, while the Sensex only showed a 1.06% increase. Similarly, SPARC's 1-month performance was -0.41%, while the Sensex's performance was -2.80%.
SPARC's strong performance can be attributed to its continuous efforts in research and development, leading to the development of innovative and effective pharmaceutical products. With its focus on midcap size, the company has been able to establish a strong presence in the market and gain the trust of investors.
Overall, Sun Pharma Advanced Research Company has shown promising growth in the stock market, making it a company to watch out for in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
